SOURCE: Diaceutics

Diaceutics

April 09, 2012 16:11 ET

Diaceutics Appoints Mark Reis as Senior Vice President of Business Development and Marketing

WASHINGTON, DC--(Marketwire - Apr 9, 2012) - Diaceutics, an international business consulting and software application firm that advises pharmaceutical companies on the development of personalized medicine, has appointed Mark Reis as Senior Vice President of Business Development and Marketing. He was most recently Director of Marketing and Business Development for DNA Direct, now a wholly owned subsidiary of Medco Health Solutions, Inc.

"Rapid growth and development of new services and products requires a full-time executive with Mark's experience to guide our global marketing efforts," said Peter Keeling, Chief Executive Officer, Diaceutics. "His work with dynamic, emerging companies -- coupled with broad industry background in genetics, pharmaceuticals and health care -- positions Mark perfectly to help us become the recognized leader in enabling pharmaceutical companies to realize the potential of personalized medicine."

Mr. Reis' previous positions at LumaSense Technologies, Inc., Philips Medical Systems, and Forbes Medi-tech, included wide-ranging responsibilities for marketing strategy and communications, sales, public and investor relations. More detail on his career and experience is available at Diaceutics' website as well as LinkedIn.

Reis holds a Bachelor of Arts degree from the University of Western Ontario, Ontario, Canada, and is completing an MBA through the Stern School of Business, New York University.

Diaceutics (www.diaceutics.com) is the leading provider of personalized medicine consulting, software and service solutions, helping the pharmaceutical industry standardize the planning, analytical and action steps needed to align the co-development of companion and other diagnostic tests with drugs for successful launch of targeted therapies. Diaceutics' proven process is currently used by 12 of the top pharmaceutical companies worldwide, delivering repeatable results and superior returns on investment.

Contact Information

  • Contact:
    Mollie Roth, Esq.
    Chief Operating Officer
    202-280-5887
    Email Contact